Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping VASOSTRICT ®, vasopressin injection, USP, in ready-to-use 100 mL pre-mix bottles.

Endo's Par sued Eagle in 2018 after it requested U.S. Food and Drug Administration approval of a generic version of Vasostrict. Chief U.S. District Judge Colm Connolly ruled last year that Eagle ...

Endo International plc’s ENDP shares ... has issued a new patent (U.S. Patent No. 9,375,478) for a drug, Vasostrict (vasopressin injection, USP) 20 units/mL, belonging to one of its operating ...

Eagle Pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP's Vasostrict. This approval follows Eagle's courtroom win in a patent dispute with Endo ...

Fresenius Kabi USA LLC on Tuesday lost an antitrust lawsuit alleging a subsidiary of rival Endo International PLC ... versions of its blood pressure drug Vasostrict from hitting the market.